Patents/Assignees

CAMURUS AB

7 patents in portfolio

US12396944utility2025
Injectable Buprenorphine Formulation
0 cites
US12318379utility2025
Opioid Formulations
0 cites
US12246055utility2025
Lipid-controlled Release Compositions
0 cites
US12161640utility2024
Opioid Formulations
0 cites
US12029813utility2024
Injectable Buprenorphine Formulation
0 cites
US11672843utility2023
Somatostatin Receptor Agonist Formulations
0 cites
US11564968utility2023
Formulations Containing a Somatostatin Receptor Agonist
0 cites